title: New guise for an old feud?
abstract: Some physicians would rather not have to buy and stock biotech drugs. Health plans are seeking ways to control the cost and distribution of injectables. Specialty pharmacy would seem to be the answer, right? Well... maybe. Removing biotech drugs from physician control carries some measure of risk for health plans - a risk that evokes memories of the payer-provider turf wars of the 1990s.
authors: Neil
authors: N
authors: Versel